Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2

International Journal of Molecular Sciences - Tập 20 Số 7 - Trang 1694
Toshihisa Komori1
1Basic and Translational Research Center for Hard Tissue Disease, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8588, Japan;

Tóm tắt

Runx2 is essential for osteoblast differentiation and chondrocyte maturation. During osteoblast differentiation, Runx2 is weakly expressed in uncommitted mesenchymal cells, and its expression is upregulated in preosteoblasts, reaches the maximal level in immature osteoblasts, and is down-regulated in mature osteoblasts. Runx2 enhances the proliferation of osteoblast progenitors by directly regulating Fgfr2 and Fgfr3. Runx2 enhances the proliferation of suture mesenchymal cells and induces their commitment into osteoblast lineage cells through the direct regulation of hedgehog (Ihh, Gli1, and Ptch1), Fgf (Fgfr2 and Fgfr3), Wnt (Tcf7, Wnt10b, and Wnt1), and Pthlh (Pthr1) signaling pathway genes, and Dlx5. Runx2 heterozygous mutation causes open fontanelle and sutures because more than half of the Runx2 gene dosage is required for the induction of these genes in suture mesenchymal cells. Runx2 regulates the proliferation of osteoblast progenitors and their differentiation into osteoblasts via reciprocal regulation with hedgehog, Fgf, Wnt, and Pthlh signaling molecules, and transcription factors, including Dlx5 and Sp7. Runx2 induces the expression of major bone matrix protein genes, including Col1a1, Spp1, Ibsp, Bglap2, and Fn1, in vitro. However, the functions of Runx2 in differentiated osteoblasts in the expression of these genes in vivo require further investigation.

Từ khóa


Tài liệu tham khảo

Komori, 2017, Roles of Runx2 in Skeletal Development, Adv. Exp. Med. Biol., 962, 83, 10.1007/978-981-10-3233-2_6

Kundu, 2002, Cbfbeta interacts with Runx2 and has a critical role in bone development, Nat. Genet., 32, 639, 10.1038/ng1050

Miller, 2002, The core-binding factor beta subunit is required for bone formation and hematopoietic maturation, Nat. Genet., 32, 645, 10.1038/ng1049

Yoshida, 2002, Core-binding factor beta interacts with Runx2 and is required for skeletal development, Nat. Genet., 32, 633, 10.1038/ng1015

Qin, 2015, Cbfb regulates bone development by stabilizing Runx family proteins, J. Bone Miner. Res., 30, 706, 10.1002/jbmr.2379

Lim, 2015, Core binding factor beta of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice, J. Bone Miner. Res., 30, 715, 10.1002/jbmr.2397

Inada, 1999, Maturational disturbance of chondrocytes in Cbfa1-deficient mice, Dev. Dyn., 214, 279, 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W

Enomoto, 2000, Cbfa1 is a positive regulatory factor in chondrocyte maturation, J. Biol. Chem., 275, 8695, 10.1074/jbc.275.12.8695

Komori, 1997, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755, 10.1016/S0092-8674(00)80258-5

Otto, 1997, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell, 89, 765, 10.1016/S0092-8674(00)80259-7

Kim, 1999, Regulation of chondrocyte differentiation by Cbfa1, Mech. Dev., 80, 159, 10.1016/S0925-4773(98)00210-X

Yoshida, 2004, Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog, Genes Dev., 18, 952, 10.1101/gad.1174704

Maruyama, 2007, Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency, Dev. Dyn., 236, 1876, 10.1002/dvdy.21187

Qin, 2018, Runx2 regulates cranial suture closure by inducing hedgehog, Fgf, Wnt, and Pthlh signaling pathway gene expression in suture mesenchymal cells, Hum. Mol. Genet., 28, 896, 10.1093/hmg/ddy386

Simpson, 2009, Trafficking, development and hedgehog, Mech. Dev., 126, 279, 10.1016/j.mod.2009.01.007

Hammerschmidt, 1999, Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation, Genes Dev., 13, 2072, 10.1101/gad.13.16.2072

Razzaque, 2005, Conditional deletion of Indian hedgehog from collagen type 2alpha1-expressing cells results in abnormal endochondral bone formation, J. Pathol., 207, 453, 10.1002/path.1870

Long, 2004, Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton, Development, 131, 1309, 10.1242/dev.01006

Rodda, 2006, Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors, Development (Cambridge, England), 133, 3231, 10.1242/dev.02480

Yang, 2014, Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation, Proc. Natl. Acad. Sci. USA, 111, 12097, 10.1073/pnas.1302703111

Zhou, X., von der Mark, K., Henry, S., Norton, W., Adams, H., and de Crombrugghe, B. (2014). Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLoS Genet., 10.

Maes, 2010, Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels, Dev. Cell, 19, 329, 10.1016/j.devcel.2010.07.010

Yoshida, C.A., Komori, H., Maruyama, Z., Miyazaki, T., Kawasaki, K., Furuichi, T., Fukuyama, R., Mori, M., Yamana, K., and Nakamura, K. (2012). SP7 Inhibits Osteoblast Differentiation at a Late Stage in Mice. PLoS ONE, 7.

Nakashima, 2002, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell, 108, 17, 10.1016/S0092-8674(01)00622-5

Kawane, 2018, Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3, Sci. Rep., 8, 13551, 10.1038/s41598-018-31853-0

Kawane, 2014, Dlx5 and Mef2 regulate a novel Runx2 enhancer for osteoblast-specific expression, J. Bone Miner. Res., 29, 1960, 10.1002/jbmr.2240

Day, 2005, Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis, Dev. Cell, 8, 739, 10.1016/j.devcel.2005.03.016

Hu, 2005, Sequential roles of Hedgehog and Wnt signaling in osteoblast development, Development (Cambridge, England), 132, 49, 10.1242/dev.01564

Hill, 2005, Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes, Dev. Cell, 8, 727, 10.1016/j.devcel.2005.02.013

Maeno, 2011, Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects, Bone, 49, 673, 10.1016/j.bone.2011.07.023

Ornitz, 1996, Receptor specificity of the fibroblast growth factor family, J. Biol. Chem., 271, 15292, 10.1074/jbc.271.25.15292

Pratap, 2003, Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts, Cancer Res., 63, 5357

Galindo, 2005, The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts, J. Biol. Chem., 280, 20274, 10.1074/jbc.M413665200

Ghali, 2010, TNF-α’s effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression, J. Bone Miner. Res., 25, 1616, 10.1002/jbmr.52

Lucero, 2013, The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines, J. Cell. Physiol., 228, 714, 10.1002/jcp.24218

Thomas, 2004, Terminal osteoblast differentiation, mediated by Runx2 and p27KIP1, is disrupted in osteosarcoma, J. Cell Biol., 167, 925, 10.1083/jcb.200409187

Zaidi, 2007, Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential, Proc. Natl. Acad. Sci. USA, 104, 19861, 10.1073/pnas.0709650104

Xiao, 2002, Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2, J. Biol. Chem., 277, 36181, 10.1074/jbc.M206057200

Kim, 2003, The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2, J. Biol. Chem., 278, 319, 10.1074/jbc.M203750200

Park, 2010, FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization, J. Biol. Chem., 285, 3568, 10.1074/jbc.M109.055053

Ge, 2009, Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor, J. Biol. Chem., 284, 32533, 10.1074/jbc.M109.040980

Mundlos, 1997, Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell, 89, 773, 10.1016/S0092-8674(00)80260-3

Lee, 1997, Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia, Nat. Genet., 16, 307, 10.1038/ng0797-307

Bradley, 1996, Studies in cranial suture biology: IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse, Plast. Reconstr. Surg., 98, 1039, 10.1097/00006534-199611000-00018

Sahar, 2005, Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture, Dev. Biol., 280, 344, 10.1016/j.ydbio.2005.01.022

Behr, 2010, Differential activation of canonical Wnt signaling determines cranial sutures fate: a novel mechanism for sagittal suture craniosynostosis, Dev. Biol., 344, 922, 10.1016/j.ydbio.2010.06.009

Mikasa, 2011, Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation, J. Bone Miner. Metab., 29, 291, 10.1007/s00774-010-0222-z

Gaur, 2005, Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression, J. Biol. Chem., 280, 33132, 10.1074/jbc.M500608200

Lee, 2005, Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter, J. Biol. Chem., 280, 35579, 10.1074/jbc.M502267200

Selvamurugan, 2000, Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1, J. Biol. Chem., 275, 5037, 10.1074/jbc.275.7.5037

Krishnan, 2003, Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling, Mol. Endocrinol., 17, 423, 10.1210/me.2002-0225

Merciris, 2007, Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo, Am. J. Pathol., 170, 1676, 10.2353/ajpath.2007.061069

Bilezikian, J.P., Raisz, L.G., and Rodan, G.A. (2002). Mesenchymal Stem Ells and Osteoblast Differentiation, Academic Press.

Toyosawa, 2001, Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts, J. Bone Miner. Res., 16, 2017, 10.1359/jbmr.2001.16.11.2017

Winkler, 2003, Osteocyte control of bone formation via sclerostin, a novel BMP antagonist, EMBO J., 22, 6267, 10.1093/emboj/cdg599

Roelen, 2004, Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist, J. Exp. Med., 199, 805, 10.1084/jem.20031454

Xiao, 2005, Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice, Dev. Biol., 283, 345, 10.1016/j.ydbio.2005.04.028

Ducy, 1997, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell, 89, 747, 10.1016/S0092-8674(00)80257-3

Sato, 1998, Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues, Oncogene, 17, 1517, 10.1038/sj.onc.1202064

Harada, 1999, Cbfa1 isoforms exert functional differences in osteoblast differentiation, J. Biol. Chem., 274, 6972, 10.1074/jbc.274.11.6972

Lee, 2000, Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12, Mol. Cell Biol., 20, 8783, 10.1128/MCB.20.23.8783-8792.2000

Banerjee, 1997, Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex, J. Cell Biochem., 66, 1, 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V

Kern, 2001, Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes, J. Biol. Chem., 276, 7101, 10.1074/jbc.M006215200

Jimenez, 1999, Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation, Mol. Cell Biol., 19, 4431, 10.1128/MCB.19.6.4431

Rossert, 1995, Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice, J. Cell Biol., 129, 1421, 10.1083/jcb.129.5.1421

Garrett, 1996, A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice, J. Cell Biol., 134, 1333, 10.1083/jcb.134.5.1333

Ivkosic, 2006, Analysis of internal deletions of a rat Col1a1 promoter fragment in transfected ROS17/2.8 cells, Coll. Antropol., 30, 401

Takarada, 2013, An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice, J. Bone Miner. Res., 28, 2064, 10.1002/jbmr.1945

Adhami, 2014, Runx2 activity in committed osteoblasts is not essential for embryonic skeletogenesis, Connect. Tissue Res., 55, 102, 10.3109/03008207.2014.923873

Bauer, 2015, Loss of osteoblast Runx3 produces severe congenital osteopenia, Mol. Cell Biol., 35, 1097, 10.1128/MCB.01106-14

Wei, 2015, Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation, Cell, 161, 1576, 10.1016/j.cell.2015.05.029

Koga, 2005, NFAT and Osterix cooperatively regulate bone formation, Nat. Med., 11, 880, 10.1038/nm1270

Ortuno, 2013, Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions, Bone, 52, 548, 10.1016/j.bone.2012.11.007

Artigas, 2014, Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program, J. Biol. Chem., 289, 27105, 10.1074/jbc.M114.576793

Baek, 2009, Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix, J. Bone Miner. Res., 24, 1055, 10.1359/jbmr.081248

Baek, 2010, Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance, Bone, 46, 920, 10.1016/j.bone.2009.12.007